Jim Cramer says he's bullish on Square, Ralph Lauren and Ulta Beauty

1 Просмотры
"This is a less in-your-face, but possibly more potent reopening [playbook] since they are being ignored, even though they should have a great year if we can just get back to normal by June," the "Mad Money" host said. Subscribe to CNBC PRO for access to investor and analyst insights: https://cnb.cx/2Vtntx6

CNBC’s Jim Cramer on Monday pulled back the curtain on five under-the-radar reopening plays as the stock market anticipates a resurgence in the American economy, turning his attention from the most talked-about recovery stocks.

The reopening thesis was furthered by federal authorization of a coronavirus vaccine from Johnson & Johnson, the third inoculation to be distributed in the U.S.

“This is a less in-your-face, but possibly more potent, reopening [playbook] since they are being ignored, even though they should have a great year if we can just get back to normal by June,” the “Mad Money” host said. “At this point, the in-your-face reopening stocks — the cruises and the airlines — I mean, can we start swapping out of those and go into some less obvious.”

On the shopping list are fintech payments company Square, designer Ralph Lauren, cosmetics company Ulta Beauty, shopping center real estate investment trust Federal Realty and automaker Ford.

The more obvious reopening plays have been in cruise lines, like Royal Caribbean, and the airlines, like Delta. Investors will find stocks in these industries to carry risk via potential equity offerings, as Royal Caribbean announced Monday, or hobbled balance sheets.

As for his new recommendations, Cramer said he expects them to gain steam in the coming weeks.

“These aren’t exactly stealth reopening stocks,” he said. “They’re more like ‘The Purloined Letter,’ hidden in plain sight, and I bet they’ll seem a lot more obvious as they go higher in the next few months.”

The new suggestions come after the market rebounded Monday following a 3% decline in the S&P 500 over the past two weeks. The S&P 500 started the new week rallying 2.38% to close above 3,900. The 30-stock Dow index rose 603 points to close at 31,535.51, a 1.95% gain. The tech-heavy Nasdaq Composite, after falling more than 6% in the past two weeks, surged 3% Monday to 13,588.83.

The U.S. Food and Drug Administration on Saturday approved Johnson & Johnson’s single-shot Covid-19 vaccine for emergency use. As opposed to the two-shot approach in the Pfizer and Moderna vaccines, JNJ’s will have fewer logistical challenges to overcome in distribution.

CEO Alex Gorsky told CNBC Monday morning that the company expects to deliver 100 million doses in the country by early summer and nearly 1 billion around the globe this year.

“That makes me think we’re much closer to the end of this long national nightmare, so it is time to unveil the less obvious reopening plays, if only because the more in-your-face ones feel a little bit overplayed,” Cramer said.

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC


Комментариев нет.